At the news
? BEARISHIMPACT 6/10 CLUSTER filed Mar 4, 2026 at 19:00 ET
Three corporate insiders at PTC Therapeutics sold shares in a coordinated 7-day window, including the Chief Medical Officer and Chief Technical Operations Officer, totaling $1.29 million in open-market transactions. The sales represent a modest but notable insider selling cluster, with executives and a director reducing holdings at current market prices.
- EVP & Chief Medical Officer Scott Golden sold 10,000 shares for $633,800 in an open-market transaction.
- Director Stephanie Okey sold 6,333 shares for $401,385.54 in an open-market transaction.
- Chief Technical Operations Officer Neil Almstead sold 3,989 shares for $252,822.82 in an open-market transaction.
- All transactions occurred on 2026-03-05 at $63.38 per share, totaling $1.288 million in aggregate.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access